SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-133541
Filing Date
2022-04-29
Accepted
2022-04-29 16:04:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d274629ddefa14a.htm DEFA14A 11026
2 GRAPHIC g274629g00g42.jpg GRAPHIC 227885
3 GRAPHIC g274629g00g43.jpg GRAPHIC 69726
  Complete submission text file 0001193125-22-133541.txt   408304
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38327 | Film No.: 22875127
SIC: 2834 Pharmaceutical Preparations